Navigation Links
Roche Women Honored as 2009 TWIN Awardees
Date:5/1/2009

NUTLEY, N.J., May 1 /PRNewswire/ -- Three Roche employees were recognized for their significant contributions to industry in New Jersey at the 2009 TWIN Awards Dinner held April 30, 2009. Honored were Nancy Shore DiLella, J.D., senior counsel and managing attorney; Theresa Martinez, marketing director for the leading hepatitis C treatment, Pegasys(R) (peginterferon alfa-2a); and Linda Lee-Mathieson, Director, Clinical Management, Pharma Development Operations.

"These individuals are exceedingly deserving of this recognition. They have made outstanding contributions to Roche, to the pharmaceutical industry as a whole and to the health and quality of life of countless people," said George Abercrombie, president and CEO of Hoffmann-la Roche Inc. "We are very proud to have them join the 82 Roche pharmaceutical employees recognized since TWIN began 35 years ago."

TWIN, which stands for Tribute to Women and INdustry, is sponsored by the YWCA of Bergen County to recognize women who have achieved responsible managerial, executive or professional positions and have made noteworthy contributions to their industries.

The Awardees

Nancy Shore DiLella, J.D., is senior counsel and managing attorney in the Corporate Law group, responsible for managing two legal teams, a regulatory legal team and the litigation group. She provides counsel on a myriad of legal issues involving products, commercial operations, functional areas, and litigation matters. DiLella has been instrumental in developing a variety of corporate policies and processes to help ensure compliance with federal and state laws and regulations, and she has played a major role in advising the company on complex commercial and government pricing issues.

"I am proud of the contributions Roche has made in the health care arena, and it has been a privilege for me to play a small role in it. It is an honor to be recognized with the TWIN Award and I am thankful to those individuals at Roche who have mentored me over the years and contributed to my professional development," said DiLella, who earned a B.S.N. in 1988 from Fairfield University in Fairfield, CT, and worked as an oncology nurse for several years before attending Seton Hall University School of Law, Newark, N.J., where she received her J.D., Cum Laude, in 1993. She clerked in New Jersey Superior Court in Morris County, then worked for the law firm of Gibbons, Del Deo before joining Roche in 1997 as senior counsel. In 2006, she was promoted to managing attorney.

"Nancy exhibits at all times the highest levels of business acumen, leadership, integrity and teamwork. She continuously strives for excellence in her own performance as well as serving as a mentor to others within the department," said Rick Kentz, Roche vice president, secretary and general counsel.

Theresa Martinez, marketing director for Pegasys, led her team in a "back-to-basics" Success campaign in the last 18 months that differentiated Pegasys through its efficacy, safety and ease of use - a message that embodied what both physicians and patients were looking for in a hepatitis C treatment. The campaign resulted in record sales results. Martinez' strong managerial and leadership qualities, including a key focus on the professional development of her team members, kept the team highly engaged and focused on driving business success.

"I was pleasantly surprised with being given the TWIN award. The success I achieved is very much a result of a team effort. I feel fortunate and blessed to be around very dedicated and hard-working people; I would not have been able to achieve such success without them," said Martinez, who grew up in the Philippines and never dreamed that much of her life would be spent outside the home she knew. In fact, she has had the opportunity to work in many different positions in various countries including the U.S., where she joined Roche four years ago as brand director in Hepatology and was promoted to marketing director in 2007. Before that, she worked for 10 years for Bayer Pharmaceuticals Corp., starting as a sales representative and rising to positions in strategic planning, division management and product management. She holds a B.S. in engineering from De La Salle University, an M.B.A. in management from Asian Institute of Management, both in the Philippines.

"Theresa's passion for understanding patient and physician needs has resulted in programs that have supported the hepatitis C community in their efforts to successfully treat this disease," said Tom Klein, vice president, Virology Sales and Marketing. "Under her direction, Pegasys has clearly established itself the market leader, and the value of the franchise has grown dramatically within Roche."

Linda Lee-Mathieson, director of Clinical Management, Pharma Development Operations, oversees more than 200 professional staff and is accountable for the delivery of global clinical studies being done to assess the safety profile of a number of important drugs, particularly in the areas of cancer, rheumatoid arthritis, viral infections, cardiovascular disease and diabetes. Her group ensures all FDA regulations and Good Clinical Practice guidelines are met for each study, and also manages a huge volume of data required for drug registration and approval.

"One of the most rewarding things about working for a company like Roche is that the products we bring to market make a difference in the world and I feel very satisfied that I have been able to be make a contribution. I was surprised and feel very honored that I have been recognized with a TWIN Award. The people who have received this award previously are real role models and I am honored to join their circle," said Lee-Mathieson, who came to Roche 32 years ago as a lab associate in Preclinical Central Nervous System (CNS) research.

In 1981, she joined the newly created Clinical Data Management group and held positions with increasing responsibilities in data management and clinical operations before being named to her current position in 2006. She earned a B.S. in psychology from St. Peter's College, Jersey City, N.J., and attended Fairleigh Dickenson Graduate School for Psychology.

"Linda has a deep knowledge base and a strong technical background, but her greatest value is her well-developed leadership qualities. She is seen as a true leader by her peers, her group and her counterparts around the world," said Cindy Dinella, PharmD, vice president, Drug Regulatory Affairs. "She also has a superb range of interpersonal skills and is viewed as an excellent coach and mentor. A less tangible, but extremely important asset, is the high degree of emotional intelligence and empathy that Linda possesses."

About Roche

Hoffmann-La Roche Inc. (Roche), based in Nutley, N.J., is the U.S. pharmaceuticals headquarters of the Roche Group, one of the world's leading research-oriented healthcare groups with core businesses in pharmaceuticals and diagnostics. For more than 100 years in the U.S., Roche has been committed to developing innovative products and services that address prevention, diagnosis and treatment of diseases, thus enhancing people's health and quality of life. An employer of choice, in 2008, Roche was named one of the Top 20 Employers (Science) and ranked the No. 1 Company to Sell For (Selling Power). In previous years, Roche has been named as Top Company of the Year by Med Ad News, a Top Company for Older Workers (AARP) and one of the Best Companies to Work For in America (Fortune). For additional information about the U.S. pharmaceuticals business, visit our website http://www.rocheusa.com. Product and treatment information for U.S. healthcare professionals is available at www.RocheExchange.com.

All trademarks used or mentioned in this release are protected by law.


'/>"/>
SOURCE Hoffmann-La Roche Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Rochester Medical Reports Second Quarter Results
2. Sanofi-Aventis and Roche/Chugais Drugs Will Dominate the Indian Colorectal Cancer Drug Market Through 2013
3. Roche Announces New Co-pay Program in Pennsylvania that Makes It Easier for Patients with Diabetes to Receive Savings on ACCU-CHEK(R) Blood Glucose Test Strips
4. Roche Announces New Co-pay Program in Florida that Makes It Easier for Patients with Diabetes to Receive Savings on ACCU-CHEK(R) Blood Glucose Test Strips
5. Roche Announces New Co-Pay Program in California That Makes it Easier for Patients With Diabetes to Receive Savings on ACCU-CHEK(R) Blood Glucose Test Strips
6. Rochester Medical Announces Second Quarter 2009 Earnings Conference Call April 30, 2009
7. Gen-Probe, Roche Prevail in Arbitration With Digene Concerning Human Papillomavirus Agreement
8. Roche Completes Acquisition of Genentech
9. The College of New Rochelle School of Nursing Receives $50,000 Grant From the Verizon Foundation for Telenursing Pilot Program
10. Roche Increases Offer Price for Genentech Shares to US$ 93.00 per Share and Extends Offer
11. Rochester Medical Renews Share Repurchase Activity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... ... February 27, 2017 , ... Silicon ... proud to announce a new informational post on robotic hair transplantation. San Francisco ... (FUE) hair transplant and Follicular Unit Transplantation (FUT) can sound similar. Either treatment ...
(Date:2/26/2017)... ... 2017 , ... This is an extension of airmid’s scope ... ISO/IEC 17025:2005 INAB accredited for Der p 1 (house dust mite allergen) & ... standard that sets out requirements for the technical competence of testing and calibration ...
(Date:2/26/2017)... ... , ... ODH, Inc.™ announced today it will exhibit and speak at ... Hotel in Arlington, VA. ODH’s director of medical strategy, Candace Saldarini, M.D., will present ... population health management. , ODH will also have an exhibit booth where attendees may ...
(Date:2/24/2017)... Houston, TX (PRWEB) , ... February 24, 2017 ... ... now offering promotions on tooth replacement options at his office, Antoine Dental Center. ... dental implants for $18,499. Some restrictions may apply, but patients can learn more ...
(Date:2/24/2017)... ... February 24, 2017 , ... The Smart Machine Age ... Oxford University predict that 47 percent of all jobs in the United States may ... and “successful.” The day of the aggressive know-it-all who steamrolls over colleagues is drawing ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... Corp. (CTI BioPharma) (NASDAQ and MTA: CTIC) today announced the ... and Chief Executive Officer (CEO) and member of the Board ... Richard Love , interim President and CEO who will continue ... has over 20 years of experience in hematology, oncology and ... . "On behalf of CTI BioPharma,s Board, ...
(Date:2/24/2017)... WOBURN, Mass. , Feb. 24, 2017 /PRNewswire/ ... that US dental labs have a new path ... abutments using the Biodenta implant library integrated into ... labs must implement FDA compliant Good Manufacturing Processes ... sub-contract manufacturer with Biodenta, and complete an audit ...
(Date:2/24/2017)... Research and Markets has announced the addition of ... to 2025" report to their offering. ... The Global Empty Capsules Market is poised to grow ... approximately $2.9 billion by 2025. This industry report analyzes ... as well as regional levels presented in the research scope. The study ...
Breaking Medicine Technology: